@domorediagnostics.com
DoMore Diagnostics is on a mission to transform cancer diagnostics with artificial intelligence to improve patient care and make drug development more effective
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
DoMore Diagnostics is a pioneering brand on a mission to revolutionize cancer diagnostics using artificial intelligence (AI) technology. By harnessing the power of AI, they aim to enhance patient care and improve the effectiveness of drug development. The brand offers a range of innovative products, including Histotype Px® and Colorectal solutions.
Histotype Px® utilizes machine learning to predict the prognosis of cancer patients using histopathology images, as published in The Lancet. Their Colorectal solution focuses on providing advanced diagnostic methods for colorectal cancer. DoMore Diagnostics has a team of experts at the helm, including Chief Executive Officer (CEO) and Co-founder, Torbjørn Furuseth, who has extensive experience in life sciences.
The team also includes Chief Technology Officer (CTO) and Co-founder, Sepp De Raedt, who has expertise in developing diagnostic and prognostic methods using machine learning. With a commitment to quality and regulatory standards, the brand is led by Head of Quality and Regulatory, Elisabeth M. J.
Klaussen, who brings a wealth of experience from the pharma, biotech, and medtech industries. Backed by an esteemed board of directors and scientific advisors, including renowned experts like Dr. John L Marshall and Prof.
Marco Novelli, DoMore Diagnostics is at the forefront of transforming cancer diagnostics and shaping the future of personalized medicine
Company Type
Privately Held
Company Size
2-10
Year Founded
2021
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online